The Effect of the Timing of Dexamethasone Administration in Patients with COVID-19 Pneumonia
Hyun Woo Lee, Jimyung Park, Jung-Kyu Lee, Tae Yeon Park, Eun Young Heo
Tuberc Respir Dis. 2021;84(3):217-225.   Published online 2021 Mar 29     DOI: https://doi.org/10.4046/trd.2021.0009
Citations to this article as recorded by Crossref logo
Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study
Sana Asif, Robert Frithiof, Anders Larsson, Stephanie Franzén, Sara Bülow Anderberg, Bjarne Kristensen, Michael Hultström, Miklos Lipcsey
Biomedicines.2023; 11(1): 164.     CrossRef
Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
Ching-Lung Lo, Ling-Shan Syue, Wen-Chien Ko
Journal of Microbiology, Immunology and Infection.2022; 55(1): 170.     CrossRef
Delayed dexamethasone treatment at initiation of oxygen supplementation for coronavirus disease 2019 is associated with the exacerbation of clinical condition
Yuta Ibe, Tomoyuki Ishigo, Satoshi Fujii, Yoshihiro Fujiya, Koji Kuronuma, Takeshi Tsugawa, Satoshi Takahashi, Masahide Fukudo
Journal of Infection and Chemotherapy.2022; 28(7): 875.     CrossRef
Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease
Elliot M. Frohman, Nicole R. Villemarette-Pittman, Adriana Rodriguez, Robert Glanzman, Sarah Rugheimer, Oleg Komogortsev, Scott S. Zamvil, Roberto Alejandro Cruz, Thomas C. Varkey, Ashley N. Frohman, Audrey R. Frohman, Matthew S. Parsons, Emily Heckmann K
Journal of the Neurological Sciences.2021; 426: 117463.     CrossRef